Featured 2 – Cancer patients may have less tolerance for targeted therapies and checkpoint inhibitors when they are used in adjuvant settings

Featured 1 – Anti-racist measures are needed to stamp out bias

Specialist trainees ‘limiting family size’ to fit program rules

RACP president-elect survives another EGM vote

Wave of ‘pharma influencers’ sidesteps drug marketing rules

Australian specialists make global research elite

MORE NEWS

more news